These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16907659)

  • 21. [A multicenter comparison of veralipride versus placebo in the vasomotor flushes of menopause. An evaluation of the prolonged effect].
    Boulot P; Viala JL
    Rev Fr Gynecol Obstet; 1988 Dec; 83(12):823-7. PubMed ID: 3064254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of an novel molecule, veralipride, in the treatment of menopausal disorders].
    Grall JY
    Sem Hop; 1982 Nov; 58(43):2535-7. PubMed ID: 6297046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Veralipride in the treatment of hot flushes in the menopause].
    Pasetto N; Piccione E; Baschieri L
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):163-5. PubMed ID: 3922035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A clinical trial of veralipride in menopausal complaints (author's transl)].
    Lefevre J
    Sem Hop; 1982 Feb; 58(7):411-3. PubMed ID: 6280313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
    Gordon S; Walsh BW; Ciaccia AV; Siddhanti S; Rosen AS; Plouffe L
    Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical study of the action of a new molecule, veralipride, on menopausal psychofunctional disorders (author's transl)].
    Delanian L
    Sem Hop; 1980 Oct; 56(37-38):1468-70. PubMed ID: 6254163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The role of Agreal in the treatment of the menopause].
    Marais C
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):156-62. PubMed ID: 3992113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of veralipride on LH, FSH, and PRL levels and on the climacteric syndrome].
    De Cecco L; Venturini PL; Alibrandi MP; Grondona AL; Morano S; Penna L; Campanella G; Ragni N
    Rev Fr Gynecol Obstet; 1985 Feb; 80(3):152-5. PubMed ID: 3922034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phytoestrogens for vasomotor menopausal symptoms.
    Lethaby AE; Brown J; Marjoribanks J; Kronenberg F; Roberts H; Eden J
    Cochrane Database Syst Rev; 2007 Oct; (4):CD001395. PubMed ID: 17943751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The menopausal hot flush--anything new?
    Sturdee DW
    Maturitas; 2008 May; 60(1):42-9. PubMed ID: 18384981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment and treatment of hot flushes and menopausal mood disturbance.
    Joffe H; Soares CN; Cohen LS
    Psychiatr Clin North Am; 2003 Sep; 26(3):563-80. PubMed ID: 14563098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Parkinson syndrome induced by veralipride].
    Franchignoni FP; Tesio L
    Minerva Ginecol; 1995 Jun; 47(6):277-9. PubMed ID: 7478098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Parkinsonism induced by sulpiride and veralipride: two different stories].
    Martí Massó JF; Ruiz-Martínez J; Bergareche A; López de Munain A
    Med Clin (Barc); 2011 Oct; 137(10):473-4. PubMed ID: 21295788
    [No Abstract]   [Full Text] [Related]  

  • 34. Menopausal hot flushes revisited.
    Andrikoula M; Prelevic G
    Climacteric; 2009 Feb; 12(1):3-15. PubMed ID: 19061056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
    Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
    J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study of veralipride in menopausal sudden flushes (author's transl)].
    Wesel S; L'Hermite M
    Sem Hop; 1980 Oct; 56(37-38):1465-7. PubMed ID: 6254162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
    Palacios S; Currie H; Mikkola TS; Dragon E
    Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cimicifuga extract BNO 1055: reduction of hot flushes and hints on antidepressant activity.
    Winterhoff H; Spengler B; Christoffel V; Butterweck V; Löhning A
    Maturitas; 2003 Mar; 44 Suppl 1():S51-8. PubMed ID: 12609559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-hormonal therapy for menopausal disorders: results of a multicentric double-blind trial (author's transl)].
    Linquette M; Rivière J; Vague J
    Sem Hop; 1980 Oct; 56(37-38):1445-8. PubMed ID: 6254159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.